ChemicalBook
English   Japanese   Germany   Korea

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile

, 38394-98-8, 结构式
CAS号:
38394-98-8
英文名:
(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile
英文别名:
Dienogest Impurity 28;Carenoprazan Impurity 7;Androst-4-ene-17-carbonitrile, 17-hydroxy-3-oxo-, (17β)-;(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile
中文名:
中文别名:
CBNumber:
CB53927783
分子式:
C20H27NO2
分子量:
313.44
MOL File:
38394-98-8.mol

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile化学性质

熔点:
201-206 °C
沸点:
498.5±45.0 °C(Predicted)
密度:
1.17±0.1 g/cm3(Predicted)
酸度系数(pKa):
11.20±0.60(Predicted)
安全信息

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile性质、用途与生产工艺

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile 上下游产品信息

上游原料

下游产品


(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile 生产厂家

供应商联系电话电子邮件国家产品数优势度
湖北国云福瑞科技有限公司 18162595016 3287908757@qq.com 中国 10012 58
China National Standard Pharmaceutical Corporation Limited +8615391658522 overseasales@yongstandards.com 中国 11927 58
 

38394-98-8, (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile 相关搜索:

  • 38394-98-8
  • Carenoprazan Impurity 7
  • Androst-4-ene-17-carbonitrile, 17-hydroxy-3-oxo-, (17β)-
  • Dienogest Impurity 28
  • (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17-carbonitrile
Copyright 2016 © ChemicalBook. All rights reserved